Objective: to analyze the clinical effect of Mongolian medicine BaoLier capsule on hyperlipidemia. Methods: a total of 120 patients with hyperlipidemia admitted to our hospital from October 2017 to October 2019 were s...Objective: to analyze the clinical effect of Mongolian medicine BaoLier capsule on hyperlipidemia. Methods: a total of 120 patients with hyperlipidemia admitted to our hospital from October 2017 to October 2019 were selected as study subjects, and 120 patients were randomly divided into study group and control group. Patients in the study group received the Mongolian medicine BaoLier capsules. The control group was given Jiangzhiling capsule. The therapeutic effects of the two groups and the decrease of total cholesterol and triglyceride were compared. Results: There was no difference in total cholesterol and triglyceride between the two groups before treatment (P>0.05). After treatment, the total cholesterol and triglyceride in the study group were significantly lower than those in the control group. The total treatment efficiency of the study group (98.33%) was significantly higher than that of the control group (78.33%). Both groups were treated with different drugs. The difference between the two groups was statistically significant (P<0.05). Conclusion: Mongolian medicine BaoLier capsule has obvious clinical effect on hyperlipidemia patients. Normal diet can play an important therapeutic role. It is an ideal treatment for hyperlipidemia and is worthy of clinical promotion.展开更多
文摘Objective: to analyze the clinical effect of Mongolian medicine BaoLier capsule on hyperlipidemia. Methods: a total of 120 patients with hyperlipidemia admitted to our hospital from October 2017 to October 2019 were selected as study subjects, and 120 patients were randomly divided into study group and control group. Patients in the study group received the Mongolian medicine BaoLier capsules. The control group was given Jiangzhiling capsule. The therapeutic effects of the two groups and the decrease of total cholesterol and triglyceride were compared. Results: There was no difference in total cholesterol and triglyceride between the two groups before treatment (P>0.05). After treatment, the total cholesterol and triglyceride in the study group were significantly lower than those in the control group. The total treatment efficiency of the study group (98.33%) was significantly higher than that of the control group (78.33%). Both groups were treated with different drugs. The difference between the two groups was statistically significant (P<0.05). Conclusion: Mongolian medicine BaoLier capsule has obvious clinical effect on hyperlipidemia patients. Normal diet can play an important therapeutic role. It is an ideal treatment for hyperlipidemia and is worthy of clinical promotion.
